{"id":"NCT01217892","sponsor":"AstraZeneca","briefTitle":"Evaluation of Dapagliflozin Taken Twice-daily","officialTitle":"A 16-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Safety and Efficacy of Dapagliflozin 2.5 mg BID, 5 mg BID and 10 mg QD Versus Placebo in Patients With Type 2 Diabetes Who Are Inadequately Controlled on Metformin-IR Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2011-08","completion":"2011-08","firstPosted":"2010-10-08","resultsPosted":"2013-11-01","lastUpdate":"2014-10-27"},"enrollment":400,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"dapagliflozin","otherNames":[]},{"type":"DRUG","name":"dapagliflozin","otherNames":[]},{"type":"DRUG","name":"dapagliflozin","otherNames":[]},{"type":"DRUG","name":"metformin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"EXPERIMENTAL"},{"label":"4","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being carried out to see if dapagliflozin - administered in a daily dose of 2.5 mg given twice a day or 5 mg twice a day or 10mg once daily - in addition to metformin, is beneficial in diabetes treatment, and if so, how it compares to treatment with metformin alone.","primaryOutcome":{"measure":"Adjusted Mean Change in HbA1c Levels","timeFrame":"Baseline to Week 16","effectByArm":[{"arm":"Dapagliflozin 2.5mg BID Plus Metformin","deltaMin":-0.52,"sd":0.0594},{"arm":"Dapagliflozin 5mg BID Plus Metformin","deltaMin":-0.65,"sd":0.06},{"arm":"Dapagliflozin 10mg OD Plus Metformin","deltaMin":-0.59,"sd":0.0598},{"arm":"Placebo Plus Metformin","deltaMin":-0.3,"sd":0.0593}],"pValues":[{"comp":"OG000 vs OG003","p":"0.0106"},{"comp":"OG001 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":55,"countries":["Germany","Hungary","Romania","Slovakia","South Africa","Switzerland","Ukraine"]},"refs":{"pmids":["25200570"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=296&filename=CSR-D1691C00003.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=296&filename=D1691C00003_Clinical_Study_Protocol_Redacted_10Jun2014.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":100},"commonTop":["HYPERTENSION","INFLUENZA"]}}